Glycoprotein IIb/IIIa Inhibitors Use and Outcome after Percutaneous Coronary Intervention for Non-ST Elevation Myocardial Infarction

Table 2

Procedural characteristics.

	No GP IIb/IIIa inhibitor used (𝑛=1753)	GP IIb/IIIa inhibitor used (𝑛=1294)	Significance (𝑃)
Access route
Radial	691 (39.4%)	383 (29.6%)	<0.001*
Brachial	1 (0.06%)	2 (0.15%)	0.267
Femoral	1061 (60.5%)	909 (70.2%)	<0.001*
Target vessel(s)
Right coronary artery	633 (36.1%)	499 (38.6%)	0.172
Left main coronary artery	36 (2.05%)	38 (2.93%)	0.123
Left anterior descending artery	662 (37.8%)	690 (53.3%)	<0.001*
Left circumflex artery	496 (28.3%)	386 (38.3%)	0.374
Bypass graft	94 (5.36%)	68 (5.26%)	0.935
Multivessel disease	401 (22.9%)	312 (24.1%)	0.436
Multivessel intervention	347 (19.8%)	401 (31.0%)	<0.001*
Drug-eluting stent used	909 (51.9%)	757 (58.5%)	<0.001*
IVUS used	86 (4.91%)	56 (4.23%)	0.487
Pressure wire used	88 (5.02%)	14 (1.08%)	<0.001*
Success	1697 (96.8%)	1286 (99.4%)	<0.001*

^∗𝑃 value < 0.05.